Atlas Trials

A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Clinical trial NCT03038802 · NOT_YET_RECRUITING

Trial details

NCT number
NCT03038802
Sponsor
Vaxine Pty Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis b
Start date
2026-03-01
Primary completion
2027-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.